a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation
Industry Biotechnology
A.I.dvisor indicates that over the last year, KPTI has been loosely correlated with NTLA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if KPTI jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To KPTI | 1D Price Change % | ||
---|---|---|---|---|
KPTI | 100% | -3.34% | ||
NTLA - KPTI | 37% Loosely correlated | -6.15% | ||
FDMT - KPTI | 37% Loosely correlated | +4.02% | ||
LCTX - KPTI | 36% Loosely correlated | -3.07% | ||
RVMD - KPTI | 35% Loosely correlated | -1.31% | ||
BEAM - KPTI | 34% Loosely correlated | -4.33% | ||
More |
Ticker / NAME | Correlation To KPTI | 1D Price Change % |
---|---|---|
KPTI | 100% | -3.34% |
cancer theme (82 stocks) | 34% Loosely correlated | -2.35% |
drugs theme (254 stocks) | 33% Poorly correlated | -1.67% |
cells theme (4 stocks) | 32% Poorly correlated | -4.72% |
treatment theme (56 stocks) | 29% Poorly correlated | -1.02% |
diseases theme (41 stocks) | 25% Poorly correlated | -1.10% |
More |